Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2009 - 2026)

Idexx Laboratories' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $44.6 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 449.88% year-over-year to $44.6 million; the TTM figure through Mar 2026 stood at $44.6 million (up 449.88% YoY), while the FY2025 annual figure was $31.9 million, down 75.89% from the prior year.
• Non-Current Deferred Tax Liability was $44.6 million for Q1 2026 at Idexx Laboratories, up from $31.9 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $132.2 million in Q4 2024 to a low of $2.1 million in Q2 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $18.7 million across 5 years, with a median of $8.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability jumped 1727.12% in 2024, then sank 79.17% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $8.2 million in 2022, then retreated by 11.23% to $7.2 million in 2023, then surged by 1727.12% to $132.2 million in 2024, then tumbled by 75.89% to $31.9 million in 2025, then jumped by 39.95% to $44.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $44.6 million (Q1 2026), $31.9 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.